The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Oragenics, Inc(NYSE MKT:OGEN) 
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. Its lead product candidate under development is OG716, an antibiotic for the treatment of Clostridium difficile. The company also engages in the development and commercialization of Terra CoV-2, a vaccine product cand...
Website: http://www.oragenics.com
Founded: 1996
Full Time Employees: 7
Sector: Healthcare
Industry: Biotechnology
Oragenics Days Payable Outstanding ttm (DPO)
Oragenics Days Receivable Outstanding ttm (DSO)
Oragenics Op Cashflow Per Share ttm
Oragenics Free Cashflow Per Share ttm
Oragenics Cash Per Share ttm
Oragenics P/S ratio ttm
Oragenics (GAAP) P/E ratio ttm
Oragenics P/B ratio ttm
No extra charts and metrics for this ticker.